Work

Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint (P8-6.008)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000202953

Authors: Gerson Hernandez Rivera, Claudia Lopez, Adam Raikes, Kathleen Rodgers, Dawn Matthews, Lon Schneider, Roberta Brinton

Institutions: University of Arizona, University of Southern California

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367305265

FWCI:

Cites:

Cited by:

Related to: 10